Article Information
History
- December 3, 2020.
Article Versions
- Version 1 (November 23, 2020 - 09:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yao Zhou1,2,
- Zipeng Liu3,
- Hongxi Yang2,4,
- Jianhua Wang1,2,
- Tong Liu5,
- Kexin Chen6,
- Yaogang Wang4,
- Pak Chung Sham3,
- Ying Yu2 and
- Mulin Jun Li1,2,6,*
- 1The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
- 2Department of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
- 3Centre for PanorOmic Sciences-Genomics and Bioinformatics Cores, The University of Hong Kong, Hong Kong
- 4Department of Health Service Management, School of Public Health, Tianjin Medical University, Tianjin, China
- 5Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China
- 6Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
- ↵*Correspondence should be addressed to Mulin Jun Li (e-mail: mulinli{at}connect.hku.hk)